Oncologist slams breast MR with old data
For the third time in less than a year, results from a retrospective study of breast cancer cases were framed as new research, challenging the routine use of MRI as a means to improve surgical outcomes in newly diagnosed breast cancer patients.
Oncologist slams breast MR with old data
For the third time in less than a year, results from a retrospective study of breast cancer cases were framed as new research, challenging the routine use of MRI as a means to improve surgical outcomes in newly diagnosed breast cancer patients. The results, announced in press releases in September 2008, June 2009, and last week, are all the same and lead to the same conclusions: newly diagnosed breast cancer who receive a breast MRI are more likely to receive a mastectomy after their diagnosis and may face delays in starting treatment. The news hook for the first press release was the 2008 ASCO Breast Cancer Symposium; for the second, online publication of the Journal of the American College of Surgeons; for the third, actual print publication in the August edition of the Journal of the American College of Surgeons. In each, Dr. Richard J. Bleicher, a surgical oncologist and attending surgeon at Fox Chase Cancer Center in Philadelphia, is quoted extensively. Dr. Bleicher could not be immediately reached for comment.
Strategies to Reduce Disparities in Interventional Radiology Care
March 19th 2025In order to help address the geographic, racial, and socioeconomic barriers that limit patient access to interventional radiology (IR) care, these authors recommend a variety of measures ranging from increased patient and physician awareness of IR to mobile IR clinics and improved understanding of social determinants of health.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.
Study: Monitoring of Prostate MRI Exams Could Lead to 75 Percent Reduction of Gadolinium Contrast
March 17th 2025While DCE MRI was deemed helpful in over 67 percent of cases in which it was used, researchers found that monitored prostate MRI exams, which facilitated a 75 percent reduction of DCE MRI sequences, had comparable sensitivity for prostate cancer as non-monitored exams.
